Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youth: The Best Evidence Synthesis is a Strong Call for Further Evidence

Publication History

Accepted: July 7, 2021

Received: June 22, 2021

Publication stageIn Press Journal Pre-ProofFootnotes

Disclosure: Dr. Cortese has served as deputy editor of Evidence-Based Mental Health, associate editor of Child and Adolescent Mental Health, and on the editorial boards of the Journal of Child Psychology and Psychiatry, the Journal of Child and Adolescent Psychopharmacology, and CNS Drugs. He has received honoraria from the Association for Child and Adolescent Mental Health, the British Association for Psychopharmacology, Healthcare Convention, and the Canadian ADHD Resource Alliance. Dr. Frazier has received grant or research support from the National Institute of Mental Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Fulcrum Therapeutics, and Roche. She has served on the editorial board of the Harvard Review of Psychiatry and as associate editor of the Journal of Child and Adolescent Psychopharmacology. Dr. Del Giovane has reported no biomedical financial interests or potential conflicts of interest.

- All statements expressed in this column are those of the authors and do not reflect the opinions of the Journal of the American Academy of Child and Adolescent Psychiatry. See the Guide for Authors for information about the preparation and submission of Editorials.

Identification

DOI: https://doi.org/10.1016/j.jaac.2021.07.004

Copyright

© 2021 Published by Elsevier Inc. on behalf of the American Academy of Child and Adolescent Psychiatry.

ScienceDirectAccess this article on ScienceDirect

留言 (0)

沒有登入
gif